INTRODUCTION
Rare disorder passed from
parents to child
Absence of an enzyme that
helps break down fatty
substances called
gangliosides
Build up to toxic levels in the
child's brain and affect the
function of the nerve cells.
MECHANISM
Tay-Sachs is an Autosomal
Recessive disease caused by
mutations in both alleles of a
gene (HEXA) on
chromosome 15 (15q24.1)
HEXA codes for the alpha
subunit of the enzyme β-
hexosaminidase A.
MECHANISM
Normally, β-hexosaminidase
A helps to degrade a lipid
called GM2 ganglioside
In Tay-Sachs individuals,
the enzyme is absent or
present only in very reduced
amounts, allowing excessive
accumulation of the GM2
ganglioside in neurons.
TYPES OF TAY-SACHS
Tay-Sachs disease is classified based on the
time of onset of neurological symptoms
Infantile TSD - Between 3 and 10 Month
(Death before the age of 4 or 5 Years)
Juvenile TSD (Between 2 and 10 Years) -
Extremely rare (Die between 5-15 Years)
Adult/Late Onset TSD (Between 20 and 30
Years)-Usually Non Fatal
DIAGNOSIS
Simple Blood Test: To measure the body's
level of hexosaminidase A (patients with
Tay-Sachs lack most or all of this protein
whereas levels are reduced in other forms of
Hexosaminidase A deficiency).
Genetic Testing (DNA): PND and PGD
Eye Examination: Classic cherry-red spot in
the center of the eye's macula (Retina part)
TREATMENT
TREATMENT GOAL
The goal of the Treatment
is Support and Comfort
MANAGEMENT WAYS:
Physical Therapy
Chest Physiotherapy
Feeding Tubes, Wheel
chairs, Canes and
Walkers
Medication (Anti-seizure)
PREVENTION
NO Cure for the Tay-
Sach Disease
Methods of Prevention:
Antenatal diagnosis (AND)
- Amniocentesis and
Chorionic Villus Sampling
Pre-implantation genetic
diagnosis (PGD)
Mate selection